ON-DEMAND WEBINARS

Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.

Gain insights on the applications of analytical techniques including Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

See how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Tom von Gunden, Chief Editor & Community Director, Drug Delivery Leader

Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:

Talk to Tom today!


Fran DeGrazio, Executive Editor - Drug Delivery Leader & Frankly Fran

In her monthly column, Fran offers keen industry insights exclusively on Drug Delivery Leader.

FRANKLY FRAN

  • In this article, Fran DeGrazio identifies four notable trends in drug delivery that gained momentum in 2025 and, she predicts, will continue to do so in 2026 and beyond. They are digitalization, sustainability, patient centricity, and the advanced delivery of complex biopharmaceuticals.

FREE EBOOK: COMBINATION PRODUCTS

Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.